Medical use of DEHP plasticiser "a concern"

EU scientific committee says some PVC devices could be be toxic to vulnerable groups but does not propose safe intake levels

The use of the phthalate softener DEHP in PVC medical devices can pose a health risk to newly-born babies, an EU scientific committee said this week. The findings turn the spotlight back onto the controversial chemical and have been welcomed by health campaigners.

But in a report delivered on Monday the committee repeated an earlier refusal to suggest a tolerable daily intake (TDI) level for DEHP from medical devices - a pre-requisite for any future EU controls based on limiting the leaching of the substance from the polymer.

Please sign in to access this article. To subscribe, view our subscription options, or take out a free trial.

Please enter your details

Forgotten password?

Having trouble signing in?

Contact Customer Support at
or call 020 8267 8120

Not a subscriber?

Take a free trial now to discover the critical insights and updates our coverage offers subscribers.